$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
罗氟司特将成COPD治疗新选择
2025-10-19 11:44:20
Check Details
罗氟司特多少钱一盒?哪里有便宜的罗氟司特
2025-10-19 11:44:20
Check Details
罗氟司特疗效好不好?罗氟司特会耐药吗
2025-10-19 11:44:20
Check Details
能倍乐(Spiolto®Respimat®)可改善哮喘患者的呼吸症状
2025-10-19 11:44:20
Check Details
慢性阻塞性肺病用药罗氟司特效果怎么样?有副作用吗?
2025-10-19 11:44:20
Check Details
罗氟司特的用法用量和注意事项是什么?
2025-10-19 11:44:20
Check Details
美国FDA 批准勃林格殷格翰慢阻肺新药能倍乐上市!
2025-10-19 11:44:20
Check Details
能倍乐的功效作用和副作用是什么呢?
2025-10-19 11:44:20
Check Details
罗氟司特治疗慢性阻塞性肺病的研究进展
2025-10-19 11:44:20
Check Details
罗氟司特的使用方法是什么?有什么副作用?
2025-10-19 11:44:20
Check Details
思力华能倍乐已在我国获批上市
2025-10-19 11:44:20
Check Details
能倍乐的使用方法和副作用你应该牢牢记住
2025-10-19 11:44:20
Check Details
1
2
...
3435
3436
3437
3438
3439
3440
3441
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
2
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
3
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
4
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
5
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
6
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis
7
Elagolix for Endometriosis Pain: Indications and Usage Guidelines
8
Bosentan vs. Antihypertensives: What PAH Patients Need to Know
9
Letermovir: Proper Usage and Important Precautions
10
FDA Approves Daraxonrasib, Marking Milestone in Metastatic Pancreatic Cancer Treatment
11
Brensocatib for Non-Cystic Fibrosis Bronchiectasis: Patient Selection, ASPEN Data, and Safety Profile
12
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas